
|Videos|April 19, 2023
Determining Treatment Efficacy in the Treatment of Myasthenia Gravis
Author(s)A. Gordon Smith, MD, FAAN
A. Gordon Smith, MD, FAAN, discusses how to assess for treatment success and why the patient perspective is so important in deciding whether to change therapies.
Advertisement
Episodes in this series

Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Key Neurology Trial Readouts to Watch in Early 2026
2
BMB-101 Heads for Registrational Trials Following Positive Phase 2 Data in Absence Seizures, Developmental Encephalopathies
3
Inside the 2026 MDA Conference: Emerging Research Themes in Neuromuscular Medicine
4
Oral Anticoagulants Do Not Raise ARIA Risk of Anti-Amyloid Alzheimer Therapies, Study Shows
5




























